{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:56:14Z","timestamp":1773294974551,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,6,25]],"date-time":"2002-06-25T00:00:00Z","timestamp":1024963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,6,25]],"date-time":"2002-06-25T00:00:00Z","timestamp":1024963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1038\/sj.jhh.1001416","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T20:12:46Z","timestamp":1031083966000},"page":"453-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Mecamylamine (Inversine\u00ae): an old antihypertensive with new research directions"],"prefix":"10.1038","volume":"16","author":[{"given":"R D","family":"Shytle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Penny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P R","family":"Sanberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,6,25]]},"reference":[{"key":"BF1001416_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0014-2999(00)00094-7","volume":"393","author":"HM Schuller","year":"2000","unstructured":"Schuller HM, Jull BA, Sheppard BJ, Plummer HK . Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders Eur J Pharmacol 2000; 393: 265\u2013277","journal-title":"Eur J Pharmacol"},{"key":"BF1001416_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/019021400269916","volume":"26","author":"HK Plummer 3rd","year":"2000","unstructured":"Plummer HK 3rd, Sheppard BJ, Schuller HM . Interaction of tobacco-specific toxicants with nicotinic cholinergic regulation of fetal pulmonary neuroendocrine cells: implications for pediatric lung disease Exp Lung Res 2000; 26: 121\u2013135","journal-title":"Exp Lung Res"},{"key":"BF1001416_CR3","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1152\/jappl.1998.84.6.2089","volume":"84","author":"AC Villablanca","year":"1998","unstructured":"Villablanca AC . Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro J Appl Physiol 1998; 84: 2089\u20132098","journal-title":"J Appl Physiol"},{"key":"BF1001416_CR4","first-page":"631","volume":"51","author":"V Saareks","year":"2000","unstructured":"Saareks V et al. Clinical pharmacology of eicosanoids, nicotine induced changes in man J Physiol Pharmacol 2000; 51: 631\u2013642","journal-title":"J Physiol Pharmacol"},{"key":"BF1001416_CR5","first-page":"169","volume":"117","author":"CA Stone","year":"1956","unstructured":"Stone CA, Torchiana ML, Navarro A, Beyer KH . Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine J Pharmacol 1956; 117: 169\u2013183","journal-title":"J Pharmacol"},{"key":"BF1001416_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1152\/ajplegacy.1956.186.1.180","volume":"186","author":"JE Baer","year":"1956","unstructured":"Baer JE, Paulson SF, Russo HF, Beyer KH . Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine) Am J Physiol 1956; 186: 180\u2013186","journal-title":"Am J Physiol"},{"key":"BF1001416_CR7","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1016\/0006-2952(89)90106-8","volume":"38","author":"BR Martin","year":"1989","unstructured":"Martin BR, Onaivi ES, Martin TJ . What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem Pharmacol 1989; 38: 3391\u20133397","journal-title":"Biochem Pharmacol"},{"key":"BF1001416_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0149-2918(01)80059-X","volume":"23","author":"JM Young","year":"2001","unstructured":"Young JM, Shytle RD, Sanberg PR, George TP . Mecamylamine: new therapeutic uses and toxicity\/risk profile Clin Ther 2001; 23: 532\u2013565","journal-title":"Clin Ther"},{"key":"BF1001416_CR9","first-page":"646","volume":"297","author":"RL Papke","year":"2001","unstructured":"Papke RL, Sanberg PR, Shytle RD . Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J Pharmacol Exp Ther 2001; 297: 646\u2013656","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1001416_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0893-133X(98)00076-1","volume":"20","author":"MS Reid","year":"1999","unstructured":"Reid MS, Mickalian JD, Delucchi KL, Berger SP . A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects Neuropsychopharmacology 1999; 20: 297\u2013307","journal-title":"Neuropsychopharmacology"},{"key":"BF1001416_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(93)90434-J","volume":"249","author":"O Blomqvist","year":"1993","unstructured":"Blomqvist O, Engel JA, Nissbrandt H, Soderpalm B . The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine Eur J Pharmacol 1993; 249: 207\u2013213","journal-title":"Eur J Pharmacol"},{"key":"BF1001416_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0091-3057(89)90061-0","volume":"32","author":"JE Rose","year":"1989","unstructured":"Rose JE, Sampson A, Levin ED, Henningfield JE . Mecamylamine increases nicotine preference and attenuates nicotine discrimination Pharmacol Biochem Behav 1989; 32: 933\u2013938","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1001416_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/clpt.1994.105","volume":"56","author":"JE Rose","year":"1994","unstructured":"Rose JE et al. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone Clin Pharmacol Therapeut 1994; 56: 86\u201399","journal-title":"Clin Pharmacol Therapeut"},{"key":"BF1001416_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1037\/1064-1297.6.3.331","volume":"6","author":"JE Rose","year":"1998","unstructured":"Rose JE, Behm FM, Westman EC . Nicotine-mecamylamine treatment for smoking cessation: the role of pre- cessation therapy Exp Clin Psychopharmacol 1998; 6: 331\u2013343","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1001416_CR15","unstructured":"Rose J, Behm F, Westman E . Brand-switching and gender effects in mecamylamine\/nicotine smoking cessation treatment In: 5th Annual Meeting of the Society for Research on Nicotine and Tobacco; 1999 March, 1999 San Diego, US: Society for Research on Nicotine and Tobacco 1999"},{"key":"BF1001416_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0278-5846(00)00178-0","volume":"25","author":"MB Newman","year":"2000","unstructured":"Newman MB et al. Corticosterone-attenutating and anxiolytic properties of mecamylamine in the rat Neuro-Psychopharmacol Biol Psych 2000; 25: 609\u2013620","journal-title":"Neuro-Psychopharmacol Biol Psych"},{"key":"BF1001416_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.42.2.382","volume":"42","author":"T Yokota","year":"1992","unstructured":"Yokota T et al. Nicotine-sensitive paresis Neurology 1992; 42: 382\u2013388","journal-title":"Neurology"},{"key":"BF1001416_CR18","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/S0024-3205(01)01338-8","volume":"69","author":"M Newman","year":"2001","unstructured":"Newman M et al. Nicotine induced seizures blocked by (\u00b1)-mecamylamine and its stereoisomers Life Sci 2001; 69: 2583\u20132591","journal-title":"Life Sci"},{"key":"BF1001416_CR19","first-page":"1101","volume":"40","author":"AA Silver","year":"2001","unstructured":"Silver AA et al. Multi-center double blind placebo controlled study of mecamylamine monotherapy for Tourette's disorder J Am Acad Child Adolescent Psych 2001; 40: 1101\u20131110","journal-title":"J Am Acad Child Adolescent Psych"},{"key":"BF1001416_CR20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","volume":"48","author":"RD Shytle","year":"2000","unstructured":"Shytle RD, Silver AA, Sanberg PR . Comorbid bipolar disorder in tourette syndrome responds to nicotinic receptor antagonist, mecamylamine (Inversine\u00ae Biol Psych 2000; 48: 1028\u20131031","journal-title":"Biol Psych"},{"key":"BF1001416_CR21","doi-asserted-by":"crossref","unstructured":"Shytle RD et al. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine Depression Anxiety 2002; (in press)","DOI":"10.1002\/da.10035"},{"key":"BF1001416_CR22","doi-asserted-by":"crossref","unstructured":"Shytle R et al. Nicotinic acetylcholine receptors as targets for antidepressants Mol Psych 2002; (in press)","DOI":"10.1038\/sj.mp.4001035"},{"key":"BF1001416_CR23","first-page":"448","volume":"50","author":"RL Braddom","year":"1969","unstructured":"Braddom RL, Johnson EW . Mecamylamine in control of hyperreflexia Arch Phys Med Rehabil 1969; 50: 448\u2013453 passim","journal-title":"Arch Phys Med Rehabil"},{"key":"BF1001416_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00002060-199110000-00002","volume":"70","author":"RL Braddom","year":"1991","unstructured":"Braddom RL, Rocco JF . Autonomic dysreflexia. A survey of current treatment Am J Phys Med Rehabil 1991; 70: 234\u2013241","journal-title":"Am J Phys Med Rehabil"},{"key":"BF1001416_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/clpt.1994.105","volume":"56","author":"JE Rose","year":"1994","unstructured":"Rose JE et al. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone Clin Pharmacol Ther 1994; 56: 86\u201399","journal-title":"Clin Pharmacol Ther"},{"key":"BF1001416_CR26","first-page":"239","volume":"49","author":"FS Tennant Jr","year":"1984","unstructured":"Tennant FS Jr ., Tarver AL, Rawson RA. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence NIDA Res Monogr 1984; 49: 239\u2013246","journal-title":"NIDA Res Monogr"},{"key":"BF1001416_CR27","first-page":"291","volume":"55","author":"FS Tennant Jr","year":"1984","unstructured":"Tennant FS Jr, Tarver AL . Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules NIDA Res Monogr 1984; 55: 291\u2013297","journal-title":"NIDA Res Monogr"},{"key":"BF1001416_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0091-3057(89)90061-0","volume":"32","author":"JE Rose","year":"1989","unstructured":"Rose JE, Sampson A, Levin ED, Henningfield JE . Mecamylamine increases nicotine preference and attenuates nicotine discrimination Pharmacol Biochem Behavr 1989; 32: 933\u2013938","journal-title":"Pharmacol Biochem Behavr"},{"key":"BF1001416_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00023210-200115050-00005","volume":"15","author":"KA Perkins","year":"2001","unstructured":"Perkins KA . Smoking cessation in women. Special considerations CNS Drugs 2001; 15: 391\u2013411","journal-title":"CNS Drugs"},{"key":"BF1001416_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1378\/chest.119.5.1357","volume":"119","author":"LC Dale","year":"2001","unstructured":"Dale LC et al. Bupropion for smoking cessation: predictors of successful outcome Chest 2001; 119: 1357\u20131364","journal-title":"Chest"},{"key":"BF1001416_CR31","first-page":"321","volume":"295","author":"JE Slemmer","year":"2000","unstructured":"Slemmer JE, Martin BR, Damaj MI . Bupropion is a nicotinic antagonist J Pharmacol Exp Ther 2000; 295: 321\u2013327","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1001416_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0272-5231(05)70015-0","volume":"21","author":"AC Villablanca","year":"2000","unstructured":"Villablanca AC, McDonald JM, Rutledge JC . Smoking and cardiovascular disease Clin Chest Med 2000; 21: 159\u2013172","journal-title":"Clin Chest Med"},{"key":"BF1001416_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/08037059609062111","volume":"5","author":"P Omvik","year":"1996","unstructured":"Omvik P . How smoking affects blood pressure Blood Press 1996; 5: 71\u201377","journal-title":"Blood Press"},{"key":"BF1001416_CR34","first-page":"81","volume":"12","author":"R Fogari","year":"1992","unstructured":"Fogari R, Zoppi A, Malamani GD, Corradi L . Effects of calcium channel blockers on cardiovascular responses to smoking in normotensive and hypertensive smokers Int J Clin Pharmacol Res 1992; 12: 81\u201388","journal-title":"Int J Clin Pharmacol Res"},{"key":"BF1001416_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/08037059709086443","volume":"6","author":"MM Ottesen","year":"1997","unstructured":"Ottesen MM, Worck R, Ibsen H . Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans Blood Press 1997; 6: 29\u201334","journal-title":"Blood Press"},{"key":"BF1001416_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2362.1979.tb00920.x","volume":"9","author":"J Trap-Jensen","year":"1979","unstructured":"Trap-Jensen J, Carlsen JE, Svendsen TL, Christensen NJ . Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans Eur J Clin Invest 1979; 9: 181\u2013183","journal-title":"Eur J Clin Invest"},{"key":"BF1001416_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1067\/mcp.2000.108066","volume":"68","author":"S Zevin","year":"2000","unstructured":"Zevin S, Jacob P 3rd, Benowitz NL . Nicotine-mecamylamine interactions Clin Pharmacol Ther 2000; 68: 58\u201366","journal-title":"Clin Pharmacol Ther"},{"key":"BF1001416_CR38","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/bmj.298.6676.784","volume":"298","author":"WY Craig","year":"1989","unstructured":"Craig WY, Palomaki GE, Haddow JE . Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data Br Med J 1989; 298: 784\u2013788","journal-title":"Br Med J"},{"key":"BF1001416_CR39","first-page":"104","volume":"9","author":"J Augustin","year":"1982","unstructured":"Augustin J, Beedgen B, Sophr U, Winkel F . The influence of smoking on plasma lipoproteins Inner Med 1982; 9: 104\u2013108","journal-title":"Inner Med"},{"key":"BF1001416_CR40","first-page":"937","volume":"37","author":"G Largue","year":"1989","unstructured":"Largue G et al. Nicotine gum and the lipid profile Patholog Biol 1989; 37: 937\u2013941","journal-title":"Patholog Biol"},{"key":"BF1001416_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0952-3278(91)90064-C","volume":"42","author":"EA Burch Jr","year":"1991","unstructured":"Burch EA Jr, Kadowitz PJ, Kother Copes SMC, Namara DB Jr . The effect of alcoholism and smoking on platelet eicosanoid production in vitro, prostaglandins, leukotrienes essential Fatty Acids 1991; 42: 39\u201344","journal-title":"Fatty Acids"},{"key":"BF1001416_CR42","first-page":"229","volume":"102","author":"FM Booyse","year":"1981","unstructured":"Booyse FM, Osikowicz G, Qarfoot AJ . Effect of Chronic Oral Consumption of Nicotine on the Rabbit Aortic Endothelium Am J Pathol 1981; 102: 229\u2013238","journal-title":"Am J Pathol"},{"key":"BF1001416_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3181\/00379727-182-3-RC1","volume":"182","author":"J Cluette-Brown","year":"1986","unstructured":"Cluette-Brown J et al. Oral nicotine induces an atherogenic lipoprotein profile Proc Soc Exp Biol Med 1986; 182: 409\u2013413","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF1001416_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000028262","volume":"58","author":"NK Kavitharaj","year":"1999","unstructured":"Kavitharaj NK, Vijayammal PL . Nicotine Administration induced changes in the gonadal functions in male rats Pharmacology 1999; 58: 2\u20137","journal-title":"Pharmacology"},{"key":"BF1001416_CR45","first-page":"367","volume":"135","author":"TH Smith","year":"1962","unstructured":"Smith TH, Rossi GV . The effect of reserpine and mecamylamine on experimental atheromatosis in the normotensive and hypertensive rat J Pharmacol Exp Ther 1962; 135: 367\u2013373","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001416","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:17:57Z","timestamp":1647541077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,25]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["BF1001416"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001416","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,25]]},"assertion":[{"value":"25 June 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}